| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 2.208 | 100.753 | 18.563 | 15.577 | 72.088 | 23.709 |
| Total Income - EUR | - | - | - | 5 | 2.413 | 100.823 | 19.200 | 19.172 | 73.232 | 23.864 |
| Total Expenses - EUR | - | - | - | 116.406 | 158.551 | 76.936 | 24.436 | 21.159 | 106.695 | 19.452 |
| Gross Profit/Loss - EUR | - | - | - | -116.401 | -156.138 | 23.887 | -5.236 | -1.987 | -33.462 | 4.412 |
| Net Profit/Loss - EUR | - | - | - | -116.401 | -156.162 | 20.967 | -5.698 | -2.413 | -33.462 | 3.706 |
| Employees | - | - | - | 2 | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Evivios Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 3.472 | 3.513 | 2.479 | 794 | 599 | 3.540 |
| Current Assets | - | - | - | 54.174 | 40.078 | 139.448 | 127.917 | 128.113 | 96.502 | 124.267 |
| Inventories | - | - | - | 26.074 | 34.485 | 68.896 | 62.298 | 38.329 | 27.697 | 50.816 |
| Receivables | - | - | - | 437 | 4.591 | 44.102 | 37.762 | 60.373 | 40.513 | 64.910 |
| Cash | - | - | - | 27.663 | 1.003 | 26.450 | 27.857 | 29.410 | 28.293 | 8.541 |
| Shareholders Funds | - | - | - | -116.358 | -270.267 | -244.176 | -244.459 | -247.631 | -280.343 | -240.732 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 170.532 | 313.817 | 387.137 | 374.855 | 376.889 | 377.762 | 368.578 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4639 - 4639" | |||||||||
| CAEN Financial Year |
4639
|
|||||||||
Comments - Evivios Med S.r.l.